> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Sets Fees for Outsource Drug Compounders
- URL: https://www.fdaweb.com/fda-sets-fees-for-outsource-drug-compounders/
- Published: 2016-08-01T12:00:00.000Z
- Updated: 2026-09-14T21:19:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5136356

*Federal Register* Notice: FDA is announcing the fiscal year (FY) 2017 rates for the establishment and re-inspection fees related to entities that compound human drugs and elect to register as outsourcing facilities under the FD&C Act. This document establishes the FY 2017 rates for the small business establishment fee ($5,279), the non-small business establishment fee ($16,852), and the re-inspection fee ($15,837) for outsourcing facilities; provides information on how the fees for FY 2017 were determined; and describes the payment procedures outsourcing facilities should follow. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-08-01/pdf/2016-18093.pdf?ref=fdaweb.com)